Works matching IS 22113428 AND DT 2020 AND VI 43 AND IP 3


Results: 14
    1
    2
    3
    4
    5
    6

    CXCL-10: a new candidate for melanoma therapy?

    Published in:
    Cellular Oncology (2211-3428), 2020, v. 43, n. 3, p. 353, doi. 10.1007/s13402-020-00501-z
    By:
    • Bagheri, Hossein;
    • Pourhanifeh, Mohammad Hossein;
    • Derakhshan, Maryam;
    • Mahjoubin-Tehran, Maryam;
    • Ghasemi, Faezeh;
    • Mousavi, Shabnam;
    • Rafiei, Rouhollah;
    • Abbaszadeh-Goudarzi, Kazem;
    • Mirzaei, Hamid Reza;
    • Mirzaei, Hamed
    Publication type:
    Article
    7

    The role of ErbB4 in cancer.

    Published in:
    Cellular Oncology (2211-3428), 2020, v. 43, n. 3, p. 335, doi. 10.1007/s13402-020-00499-4
    By:
    • Segers, Vincent F.M.;
    • Dugaucquier, Lindsey;
    • Feyen, Eline;
    • Shakeri, Hadis;
    • De Keulenaer, Gilles W.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    Prevalence of CD8+ cytotoxic lymphocytes in human neoplasms.

    Published in:
    Cellular Oncology (2211-3428), 2020, v. 43, n. 3, p. 421, doi. 10.1007/s13402-020-00496-7
    By:
    • Blessin, Niclas C.;
    • Spriestersbach, Patrick;
    • Li, Wenchao;
    • Mandelkow, Tim;
    • Dum, David;
    • Simon, Ronald;
    • Hube-Magg, Claudia;
    • Lutz, Florian;
    • Viehweger, Florian;
    • Lennartz, Maximillian;
    • Fraune, Christoph;
    • Nickelsen, Vera;
    • Fehrle, Wilfried;
    • Göbel, Cosima;
    • Weidemann, Sören;
    • Clauditz, Till;
    • Lebok, Patrick;
    • Möller, Katharina;
    • Steurer, Stefan;
    • Izbicki, Jacob R.
    Publication type:
    Article